ORBIMED ADVISORS LLC – VistaGen Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-82.72%
quarter
VistaGen Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -13.42M shares | -11.81M | $0.15 | 0 |
Q2 2022 | share | Increase | +3.97% | 512K shares | -4.19M | $0.88 | 13.42M |
Q1 2022 | share | 0.00% | 0 shares | -9.16M | $1.24 | 12.90M | |
Q4 2021 | share | 0.00% | 0 shares | -10.19M | $2.04 | 12.90M | |
Q3 2021 | share | Decrease | -10.77% | -1.55M shares | -10.20M | $2.74 | 12.90M |
Q2 2021 | share | Increase | +68.15% | 5.86M shares | 27.24M | $3.15 | 14.46M |
Q1 2021 | share | Increase | +14.72% | 1.10M shares | 3.77M | $2.13 | 8.60M |
Q4 2020 | share | Increase | 0.00% | 7.5M shares | 14.55M | $1.94 | 7.5M |